StemMACS™ DAPT is a small molecule inhibitor of gamma-secretase that prevents Notch signaling.
StemMACS™ DAPT is a small molecule inhibitor of gamma-secretase that prevents Notch signaling.
StemMACS™ DAPT is a cell-permeable dipeptide that inhibits the protease γ-secretase, a key component of the Notch signaling pathway. The Notch pathway is involved in various developmental cell fate and lineage decisions, making the small molecule inhibitor DAPT a valuable tool for the modulation of stem cell differentiation in cell culture. In addition, γ-secretase plays a role in processing of amyloid precursor protein (APP) to β-amyloid, a component of the senile plaques characteristic for Alzheimer’s disease. Inhibition of γ-secretase by DAPT has been shown to cause a dose-dependent reduction of β-amyloid levels in primary neuronal cultures as well as in vivo.
Published applications for DAPT include:
- Differentiation of human PSCs into retinal pigment epithelium (RPE) cells1
- Neural differentiation of human PSCs2
- Pancreatic differentiation of human PSCs3
- Nociceptor differentiation from human PSCs4
Chemical structure of StemMACS™ DAPT
- Osakada, F. et al. (2009) Stepwise differentiation of pluripotent stem cells into retinal cells. Nat. Protoc. 4 (6): 811-824
- D'Amour, K. A. et al. (2006) Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat. Biotechnol. 24: 1392-1401
- Elkabetz, Y. et al. (2008) Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage. Genes Dev. 22 (2): 152-165
- Chambers, S. M. et al. (2012) Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors. Nat. Biotechnol. 30 (7): 715-720